文献速递区域麻醉与超声疼痛医学

脂质体布比卡因镇痛效果不一致的因素分析

Liposomal bupivacaine: examining the factors behind inconsistent analgesic results.
PubMed 文献 · Reg Anesth Pain Med · 2026-03-05

Liposomal bupivacaine (LB) has been the subject of a great deal of study, and some degree of controversy, since its development in the late 1990s.…

要点

  • LB疗效研究结果不一致,部分显示有效,许多显示无效或仅边际改善。
  • 与普通局麻药相比,LB成本显著增加。
  • 神经周围解剖可能影响LB提供长效镇痛的潜力。

核心结论

  • LB的镇痛疗效研究结果不一致,部分研究支持其有效性,许多研究则不支持或仅显示边际改善。

研究设计与样本

  • 教育性综述,回顾LB的开发历程、药理学要点及疗效不一致的可能原因。

主要发现

  • 神经周围解剖的一些方面可能影响LB提供长效镇痛的潜力。

临床怎么用

  • 临床使用LB时应考虑其疗效证据不一致及成本显著增加的问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Liposomal bupivacaine (LB) has been the subject of a great deal of study, and some degree of controversy, since its development in the late 1990s. While some published studies are supportive of its efficacy, many others are not or demonstrate only marginal improvement in analgesia. This variable efficacy occurs in the face of markedly increased costs when compared with plain local anesthetics. In this education article, we trace the development of LB, summarize the important aspects of its pharmacology, and explore possible causes of its failure to fulfill the promise that the drug held when it was developed and approved. Finally, we discuss some aspects of perineural anatomy that might impact the potential of this drug to provide long-lasting analgesia.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Orebaugh SL, Ligocki M, Guo H, et al. Liposomal bupivacaine: examining the factors behind inconsistent analgesic results. Reg Anesth Pain Med. 2026. PMID: 39961728. doi:10.1136/rapm-2024-106189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。